TAKE THIS POLL |
|
|
- UPI NewsTrack Health and Science News 4 Jul 2009 00:02 GMT
... than 20 years, river blindness has been controlled with ivermectin, a drug developed by Merck & Co. Ivermectin, however, kills only the larvae so treatments of at least 11 to 14 years ...
- New 'river blindness' drug shows promise 3 Jul 2009 17:30 GMT
... than 20 years, river blindness has been controlled with ivermectin, a drug developed by Merck & Co. Ivermectin, however, kills only the larvae so treatments of at least 11 to 14 years ...
- Addex to Host R&D Day on July 16 3 Jul 2009 10:30 GMT
... allosteric modulators to treat anxiety and schizophrenia. In addition, in two separate agreements with Merck & Co., Inc., we are developing allosteric modulators as drugs to treat Parkinson's disease and schizophrenia, ...
- Wall Street News Alert: 4 Stocks You Need to Know for Wednesday -- July 1, 2009 3 Jul 2009 09:12 GMT
... News Alert's "stocks to watch" this morning are: PrimeGen Energy Corporation ( ) and Merck & Co., Inc. ( To receive FREE Mobile Stock Alerts formatted especially for your cell phone, ...
- Allied Healthcare International Inc. Elects Dr. Jeffrey S. Peris as Non-Executive Chairman of the Bo 3 Jul 2009 08:33 GMT
... companies from 1997 until 1998. From 1972 until 1997, Dr. Peris was employed by Merck Co., Inc., a leading, global pharmaceutical company, where he served in senior executive officer roles in ...
- Fawcett has become poster girl for anal cancer 2 Jul 2009 21:23 GMT
... get the vaccine, a decision Lerner applauded. “I think that to the degree that Merck and advocates for the disease are being cautious, that's great,” he said. But all of this ...
- Johnson & Johnson Pays $1B For Elan Stake 2 Jul 2009 20:32 GMT
... with Schering-Plough" over shared sales of arthritis drugs because Schering is being acquired by Merck & Co. for $41.1 billion, said analyst Steve Brozak of WBB Securities. Meanwhile, Wyeth is being bought ...
- BUYINS.NET: NOVL, WSCC, GCO, CRXL, HA, WBD Are Seasonally Biased To Go Lower In The Next 5 Weeks 2 Jul 2009 16:52 GMT
... industry. Important partners and licensees include DSM Biologics, sanofi-aventis, Novartis, Wyeth, GSK, CSL and Merck & Co. Crucell is headquartered in Leiden, the Netherlands, with subsidiaries in Switzerland, Spain, Italy, Sweden, Korea ...
- Fawcett's death from rare disease may remove stigma from a taboo topic: experts 2 Jul 2009 14:31 GMT
... get the vaccine, a decision Lerner applauded. "I think that to the degree that Merck and advocates for the disease are being cautious, that's great," he said. But all of this ...
- Monthly Pet Pill Could Kill Fleas, Ticks 2 Jul 2009 13:50 GMT
... with the results of a recently released study. In the study, researchers with the Merck & Co. pharmaceutical company report that a drug called nodulisporic acid effectively and safely killed fleas and ...
- Fawcett death puts focus on anal cancer 2 Jul 2009 13:31 GMT
... is not yet completed. Those results are expected later this year. The vaccine's manufacturer, Merck & Co., has declined to cite Fawcett's case as a reason for women who get the ...
- SCANCELL HOLDINGS PLC - Merck Serono Licensing Agreement 2 Jul 2009 08:52 GMT
... SCANCELL HOLDINGS PLC - Merck Serono Licensing Agreement Thu. July 02, 2009; Posted: 04:27 AM Jul 02, 2009 (PR Newswire ...
- New Drug That Could Dramatically Speed Up The Elimination Of River Blindness Across Africa Begins Clinical Trial 2 Jul 2009 08:50 GMT
... ivermectin, which has been donated for more than 20 years by the pharmaceutical company Merck & Co., Inc., for use in onchocerciasis endemic countries. Treatment with ivermectin has enabled significant progress ...
- Merck not sure why trial AIDS vaccine failed in volunteers 2 Jul 2009 05:52 GMT
... Merck not sure why trial AIDS vaccine failed in volunteers Last Updated: Thursday, November 8, 2007 | ...
- Rx for medical research - networks 2 Jul 2009 04:52 GMT
... to yield results. For instance, more than a third of the metabolism drugs in Merck's current pipeline were derived using this methodology. The difficulty of transitioning science from a linear ...
- Moxidectin being tested for onchocerciasis 2 Jul 2009 02:52 GMT
... ivermectin, which has been donated for more than 20 years by the pharmaceutical company Merck & Co. for use in onchocerciasis endemic countries. Treatment with ivermectin has enabled significant progress in the ...
- Farrah Fawcett's death spotlights a rare cancer 2 Jul 2009 00:31 GMT
... is not yet completed. Those results are expected later this year. The vaccine's manufacturer, Merck & Co., has declined to cite Fawcett's case as a reason for women who get the ...
- Fawcett's death spotlights a rare cancer 2 Jul 2009 00:31 GMT
... is not yet completed. Those results are expected later this year. The vaccine's manufacturer, Merck & Co., has declined to cite Fawcett's case as a reason for women who get the ...
- ATLANTA In a perverse twist of medical fate, Farrah Fawcett has become the poster girl for anal cancer, a rare disease often linked to a sexually transmitted virus. 1 Jul 2009 22:51 GMT
... is not yet completed. Those results are expected later this year. The vaccine’s manufacturer, Merck & Co., has declined to cite Fawcett’s case as a reason for women who get the ...
- Farrah Fawcett's death from rare disease may remove stigma from a taboo topic, experts say 1 Jul 2009 22:51 GMT
... is not yet completed. Those results are expected later this year. The vaccine's manufacturer, Merck & Co., has declined to cite Fawcett's case as a reason for women who get the ...
- Fawcett's death spotlights a rare cancer 1 Jul 2009 20:23 GMT
... is not yet completed. Those results are expected later this year. The vaccine's manufacturer, Merck & Co., has declined to cite Fawcett's case as a reason for women who get the ...
- Trial of drug to eliminate river blindness in Africa begins 1 Jul 2009 18:22 GMT
... ivermectin, which has been donated for more than 20 years by the pharmaceutical company Merck & Co., Inc., for use in onchocerciasis endemic countries. Treatment with ivermectin has enabled significant progress ...
- Allied Healthcare International Inc. Elects Dr. Jeffrey S. Peris as Non-Executive Chairman of the Bo 1 Jul 2009 15:12 GMT
... companies from 1997 until 1998. From 1972 until 1997, Dr. Peris was employed by Merck Co., Inc., a leading, global pharmaceutical company, where he served in senior executive officer roles in ...
- Allied Healthcare International Elects Dr. Peris 1 Jul 2009 15:12 GMT
... companies from 1997 until 1998. From 1972 until 1997, Dr. Peris was employed by Merck Co., Inc., a leading, global pharmaceutical company, where he served in senior executive officer roles in ...
- Allied Healthcare International Inc. Elects Dr. Jeffrey S. Peris as Non-Executive Chairman of the Board 1 Jul 2009 15:10 GMT
... companies from 1997 until 1998. From 1972 until 1997, Dr. Peris was employed by Merck Co., Inc., a leading, global pharmaceutical company, where he served in senior executive officer roles in ...
1 - 25 of 283 next >
Powered by 
News by PR Newswire
24-7 pressrelease
Emailwire
|